Company Filing History:
2 out of 25 
2 out of 76 
1 out of 1 Years Active: 2012-2020
Title: Brent T. Hagen: Innovator in Oligosialic Acid Derivatives
Introduction
Brent T. Hagen is a notable inventor based in Oakland, California. He has made significant contributions to the field of biochemistry, particularly in the development of oligosialic acid derivatives. With a total of five patents to his name, his work has implications in immunology and cancer treatment.
Latest Patents
Hagen's latest patents focus on the production and application of isolated alpha (2→8) or (2→9) oligosialic acid derivatives. These derivatives are characterized by a non-reducing end enriched with de-N-acetyl residues, which are resistant to degradation by exoneuraminidase. The production method involves treating an oligosialic acid precursor with sodium borohydride to achieve de-N-acetylation. The resulting derivatives have potential uses in protecting against bacterial infections and in diagnosing and treating cancer.
Career Highlights
Throughout his career, Brent T. Hagen has worked with esteemed institutions such as Children's Hospital & Research Center Oakland. His research has contributed to advancements in immunological applications and therapeutic methods.
Collaborations
Hagen has collaborated with Gregory R. Moe, enhancing the scope and impact of his research endeavors.
Conclusion
Brent T. Hagen's innovative work in oligosialic acid derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the fields of immunology and oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.